查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722583

2025 年至 2033 年兽医市场报告（依产品、动物类型、给药途径、配销通路及地区）

Veterinary Medicine Market Report by Product, Animal Type, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球兽药市场规模达 374 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 604 亿美元，2025-2033 年期间的成长率 (CAGR) 为 5.47%。宠物拥有量的增加、诊断和治疗技术的重大进步、对牲畜食品安全和疾病控制的需求不断增加、政府促进动物健康的倡议、该领域的持续研究和开发以及对生产动物和伴侣动物的兽医护理的需求是推动市场发展的一些主要因素。

兽医学是医学科学的一个专门分支，主要关注动物的健康和福祉。它涵盖各种动物物种的疾病、损伤和紊乱的诊断、治疗和预防。它在促进动物健康、福利和公共健康方面发挥着至关重要的作用。兽医是经过专业训练的兽医专业人员，负责为动物提供医疗服务，包括家养宠物、牲畜、野生动物和实验动物。他们进行全面检查、诊断测试、开药、进行手术并提供疫苗接种等预防性护理。兽医学领域涵盖多个学科，包括内科、外科、皮肤病学、放射学、病理学和牙科。兽医与宠物主人、牲畜饲养者、动物园管理员以及动物行业的其他专业人士密切合作，以确保他们照顾的动物的健康。

宠物拥有量的上升趋势，尤其是在城市地区，正在推动对兽医药物的需求。宠物主人越来越多地寻求兽医服务来进行常规检查、接种疫苗和医疗保健需求，从而推动了市场的成长。此外，人们更加重视动物福利和预防性护理，从而提高了对动物药物重要性的认识。宠物主人和畜牧养殖户认识到定期看兽医以确保动物整体健康和福祉的重要性。除此之外，可以透过动物传播给人类的人畜共通传染病近年来也受到了广泛关注。此外，禽流感和新冠肺炎等疾病的爆发凸显了对有效兽医药物预防和控制此类疾病的必要性，从而导致对动物健康的投资增加。除此之外，对肉类、乳製品和其他动物性食品的需求不断增长，也增加了畜牧业对兽药的需求。确保农场动物的健康和福祉对于维持食品安全标准和满足不断增长的消费者需求至关重要。除此之外，诊断影像、实验室检测和外科手术技术等兽医技术的进步显着改善了动物疾病的诊断和治疗。此外，针对动物健康和福利的政府法规和措施在塑造市场方面发挥着至关重要的作用。

兽医市场趋势/驱动因素：

宠物拥有量增加

宠物拥有量的增加趋势是市场的一个重要动力。随着越来越多的人选择饲养宠物，兽医服务的需求也随之增加。宠物主人越来越意识到定期进行兽医护理的重要性，以确保他们毛茸茸的伙伴的健康和福祉。他们寻求预防措施，例如接种疫苗、定期检查以及治疗跳蚤、蜱虫和牙齿问题等常见疾病。对兽医服务日益增长的需求为专门从事兽医的诊所、医院和製药公司创造了机会。此外，宠物主人与动物之间的情感纽带促使他们愿意投资宠物的医疗保健，从而进一步促进市场成长。

技术进步

技术进步彻底改变了兽医领域，推动了市场成长。数位放射成像和超音波等诊断成像的创新使得诊断更加准确和及时。先进的实验室检测方法可以更快、更准确地识别疾病。包括微创手术和雷射手术在内的手术技术改善了患者的治疗效果并缩短了恢復时间。这些技术进步不仅提高了护理质量，而且增加了对兽医服务的需求。采用这些技术的兽医诊所获得了竞争优势，并吸引了更多寻求最先进动物护理的客户。

畜牧业生产与食品安全

畜牧生产对兽医的需求源自于确保动物健康、福利和食品安全的需求。随着全球人口的增长和肉类消费的增加，畜牧农民面临满足动物性食品需求的挑战。它在维持牲畜健康和生产力方面发挥着至关重要的作用。定期的兽医护理、疾病预防计划和适当的管理实践有助于提高产品品质并降低食源性疾病的风险。消费者对食品安全和动物道德待遇的担忧进一步强调了畜牧业对强有力的兽医保健的必要性。因此，对兽医和动物健康管理的投资持续成长，支持了市场的扩张。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球兽医市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 药物
    • 关键部分
      • 抗感染
      • 消炎剂
      • 杀寄生虫剂
  • 疫苗
    • 关键部分
      • 灭活疫苗
      • 减毒疫苗
      • 重组疫苗
  • 药物饲料添加剂
    • 关键部分
      • 胺基酸
      • 抗生素

第七章：市场区隔：依动物类型

  • 生产
  • 伴侣

第八章：市场区隔：依行政途径

  • 口服
  • 肠外
  • 外用

第九章：市场区隔：按配销通路

  • 兽医医院和诊所
  • 即时检验/内部检验
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Archer-Daniels-Midland Company
    • Boehringer Ingelheim GmbH
    • Cargill Incorporated
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Evonik Industries AG
    • Merck & Co. Inc.
    • Neogen Corporation
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112025A5627

The global veterinary medicine market size reached USD 37.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 60.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The increasing pet ownership, significant technological advancements in diagnostics and treatments, rising need for food safety and disease control in livestock, government initiatives promoting animal health, and ongoing research and development in the field and the demand for veterinary care in both production and companion animals are some of the major factors propelling the market.

Veterinary medicine is a specialized branch of medical science that focuses on the health and well-being of animals. It encompasses the diagnosis, treatment, and prevention of diseases, injuries, and disorders in various animal species. It plays a crucial role in promoting animal health, welfare, and public health. Veterinarians, trained professionals in veterinary medicine, are responsible for providing medical care to animals, including domestic pets, livestock, wildlife, and laboratory animals. They conduct thorough examinations, perform diagnostic tests, prescribe medications, perform surgeries, and provide preventive care such as vaccinations. The field of veterinary medicine encompasses various disciplines, including internal medicine, surgery, dermatology, radiology, pathology, and dentistry. Veterinarians work closely with pet owners, livestock farmers, zookeepers, and other professionals in the animal industry to ensure the well-being of animals under their care.

The rising trend of pet ownership, particularly in urban areas, is driving the demand for veterinary medicine. Pet owners are increasingly seeking veterinary services for routine check-ups, vaccinations, and healthcare needs, thus fueling the growth of the market. Additionally, there is a greater emphasis on animal welfare and preventive care, leading to increased awareness regarding the importance of medicine for animals. Pet owners and livestock farmers are recognizing the significance of regular veterinary visits to ensure the overall health and well-being of their animals. Other than this, zoonotic diseases, which can be transmitted from animals to humans, have gained significant attention in recent years. Furthermore, the outbreak of diseases like avian influenza and COVID-19 have highlighted the need for effective veterinary medicine to prevent and control such diseases, leading to increased investments in animal health. Besides this, the growing demand for meat, dairy products, and other animal-derived food products has increased the need for veterinary medicine in livestock production. Ensuring the health and well-being of farm animals is crucial for maintaining food safety standards and meeting the rising consumer demand. Besides this, advancements in veterinary technology, such as diagnostic imaging, laboratory testing, and surgical techniques, have significantly improved the diagnosis and treatment of animal diseases. Moreover, government regulations and initiatives aimed at animal health and welfare play a vital role in shaping the market.

Veterinary Medicine Market Trends/Drivers:

Increasing pet ownership

The increasing trend of pet ownership is a significant driver of the market. As more people choose to have pets, the demand for veterinary services rises accordingly. Pet owners are increasingly aware of the importance of regular veterinary care to ensure the health and well-being of their furry companions. They seek preventive measures such as vaccinations, regular check-ups, and treatments for common conditions like fleas, ticks, and dental problems. This growing demand for veterinary services creates opportunities for clinics, hospitals, and pharmaceutical companies specializing in veterinary medicine. Additionally, the emotional bond between pet owners and their animals drives the willingness to invest in their healthcare, leading to further market growth.

Technological advancements

Technological advancements have revolutionized the field of veterinary medicine, driving market growth. Innovations in diagnostic imaging, such as digital radiography and ultrasound, enable more accurate and timely diagnoses. Advanced laboratory testing methods allow for quicker and more precise identification of diseases. Surgical techniques, including minimally invasive procedures and laser surgery, have improved patient outcomes and reduced recovery times. These technological advancements not only enhance the quality of care but also increase the demand for veterinary services. Veterinary practices that adopt these technologies gain a competitive edge and attract a larger client base seeking state-of-the-art care for their animals.

Livestock production and food safety

The demand for veterinary medicine in livestock production is driven by the need to ensure animal health, welfare, and food safety. With the increasing global population and rising meat consumption, livestock farmers face the challenge of meeting the demand for animal-derived food products. It plays a crucial role in maintaining the health and productivity of livestock. Regular veterinary care, disease prevention programs, and proper management practices contribute to higher-quality products and reduce the risk of foodborne illnesses. Consumer concerns regarding food safety and the ethical treatment of animals further emphasize the need for robust veterinary healthcare in the livestock industry. As a result, investments in veterinary medicine and animal health management continue to grow, supporting the expansion of the market.

Veterinary Medicine Industry Segmentation:

Breakup by Product:

  • Drugs
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Medicated Feed Additives
  • Amino Acids
  • Antibiotics

Drugs play a crucial role in the treatment and management of animal diseases and conditions. Veterinary drugs include a wide range of pharmaceutical products such as antibiotics, anti-inflammatory drugs, antiparasitics, analgesics, and hormonal therapies. These drugs are specifically formulated and approved for use in animals to address various health issues. The market for veterinary drugs is driven by the need for effective treatment options, advancements in drug development, and the growing prevalence of animal diseases.

Vaccines stimulate an immune response in animals, providing protection against specific diseases. Veterinary vaccines help prevent the spread of infectious diseases and reduce the severity of outbreaks in animals. They are used in both companion animals and livestock, contributing to the overall health and well-being of the animal population. The demand for veterinary vaccines is driven by increased awareness of preventive healthcare, government regulations promoting vaccination programs, and the focus on disease control in animal populations.

Medicated feed additives are substances added to animal feed to deliver specific medications or nutritional supplements. These additives can contain drugs, vitamins, minerals, or other bioactive compounds to improve animal health, enhance growth performance, or prevent and control diseases. Medicated feed additives are commonly used in livestock production, where they contribute to optimized feed efficiency, disease prevention, and overall animal well-being. The market for medicated feed additives is driven by the demand for improved feed quality, the need for efficient disease prevention in large-scale farming, and the emphasis on maximizing productivity in the livestock industry.

Breakup by Animal Type:

  • Production
  • Companion

Production holds the largest share in the market

The market for production animals encompasses livestock and poultry, including cattle, swine, poultry, sheep, and fish. These animals are primarily raised for meat, milk, eggs, and other animal-derived products. The veterinary care for production animals focuses on disease prevention, herd health management, reproductive health, and nutrition. The market for production animals is driven by the increasing global demand for animal protein, advancements in livestock farming practices, the need to ensure food safety, and the emphasis on sustainable and efficient production methods.

The market for companion animals includes domestic pets such as dogs, cats, and exotic pets like birds, reptiles, and small mammals. Companion animal care encompasses a wide range of veterinary services, including preventive care, vaccinations, routine check-ups, dental care, and treatment for various health conditions. The market for companion animals is driven by the growing pet ownership trends, increased awareness of pet health and well-being, the emotional bond between pet owners and their animals, and the demand for high-quality veterinary care, diagnostics, medications, and pet products. The focus on pet health and the willingness to invest in their care contribute to the growth of this segment of the market.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical

Parenteral dominates the market

Oral administration refers to the delivery of veterinary medications or treatments through the oral route, typically in the form of tablets, capsules, liquids, or feed additives. Oral administration is commonly used in veterinary medicine due to its convenience and ease of use. It allows for controlled dosing, long-lasting effects, and can be administered directly by the animal owner or mixed with food. The market for oral administration products in veterinary medicine is driven by the wide range of oral medications available, the preference for non-invasive administration methods, and the need for medications that can be easily administered to animals at home or on farms.

Parenteral administration involves the delivery of veterinary medications or treatments through routes other than the digestive tract, such as injections (intravenous, intramuscular, subcutaneous), infusions, or implantations. Parenteral administration allows for rapid absorption and immediate effect, making it suitable for emergencies, critical conditions, or situations where precise dosing is required. The market for parenteral administration products in veterinary medicine is driven by the need for fast-acting medications, the ability to administer drugs in a controlled and accurate manner, and the demand for injectable vaccines, antibiotics, anesthetics, and other treatments in both production and companion animals.

Topical administration involves the application of veterinary medications or treatments directly to the skin or mucous membranes of animals. This can include ointments, creams, sprays, powders, or spot-on treatments. Topical administration is commonly used for localized treatment of skin conditions, external parasites, wound care, or eye and ear ailments. It offers localized therapeutic effects, ease of application, and reduced systemic side effects. The market for topical administration products in veterinary medicine is driven by the demand for dermatological treatments, flea and tick control products, wound management solutions, and other topical medications for both companion and production animals.

Breakup by Distribution Channel:

  • Veterinary Hospitals and Clinics
  • Point-of-Care Testing/In-house Testing
  • Others

Veterinary hospitals and clinics represent the largest distribution channel

Veterinary hospitals and clinics serve as primary points of care for animals, providing a wide range of veterinary services, including examinations, diagnostics, treatments, surgeries, and preventive care. They have well-equipped laboratories, pharmacy services, and access to a variety of veterinary medications and products. Veterinary hospitals and clinics play a vital role in the distribution of prescription medications, specialized diets, and other veterinary products. They often have established relationships with pharmaceutical companies and distributors to ensure the availability of a diverse range of veterinary medications and supplies.

Point-of-care testing, also known as in-house testing, refers to diagnostic tests conducted on-site at veterinary clinics or hospitals. These tests allow for rapid and immediate results, enabling veterinarians to make timely treatment decisions. Point-of-care testing encompasses various diagnostic methods, including blood tests, urine tests, imaging technologies, and molecular diagnostics. The market for point-of-care testing is driven by the increasing demand for quick and accurate diagnoses, convenience, and the ability to provide immediate care to animals. Veterinary clinics and hospitals invest in point-of-care testing equipment and kits to enhance their diagnostic capabilities and offer comprehensive veterinary services in a timely manner.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for veterinary medicines.

North America comprises the United States and Canada, which have well-established veterinary healthcare systems and a large population of both companion and production animals. The market in North America is driven by factors such as the increasing pet ownership, rising demand for quality animal healthcare, advancements in veterinary technology, and a strong focus on animal welfare. The region has a well-developed network of veterinary hospitals, clinics, and specialized veterinary care providers. Additionally, there is significant investment in research and development, leading to the introduction of new veterinary drugs, vaccines, and diagnostic tools. North America also has stringent regulations regarding animal health and welfare, driving the demand for veterinary products and services.

Europe represents a substantial market for veterinary medicine, encompassing countries such as the United Kingdom, Germany, France, and Italy. The market in Europe is driven by factors such as a large population of companion animals, a strong focus on preventive healthcare, stringent regulatory standards, and a high level of pet ownership. European countries have well-established veterinary healthcare systems, with a wide network of veterinary clinics, hospitals, and specialized centers. The region emphasizes the importance of vaccination programs, disease control, and public health concerns related to zoonotic diseases. Additionally, Europe is witnessing advancements in veterinary technology, research collaborations, and investments in innovative treatment modalities, further driving the market growth.

The Asia Pacific region represents a rapidly growing market for veterinary medicine. The region comprises countries such as China, Japan, India, Australia, and emerging economies in Southeast Asia. The market in Asia Pacific is driven by factors such as the increasing disposable income, urbanization, rising pet ownership, and growing demand for animal-derived food products. Asia Pacific has a large population of both companion and production animals, contributing to the demand for veterinary services. The region also witnesses the rising adoption of Western veterinary practices and an increasing focus on animal welfare and preventive healthcare. With the expansion of the middle class and the evolving livestock industry, there is a growing need for advanced veterinary products, diagnostic tools, vaccines, and medications. The market in Asia Pacific is supported by investments in veterinary infrastructure, research and development, and government initiatives promoting animal health and welfare.

Competitive Landscape:

Key players invest significantly in research and development to innovate and introduce new veterinary drugs, vaccines, diagnostic tools, and treatment modalities. R&D efforts focus on enhancing the efficacy, safety, and convenience of veterinary products, as well as developing novel therapies for animal health conditions. Companies collaborate with research institutions and veterinary experts to stay at the forefront of advancements in the field. Additionally, key players strive to expand their product portfolios by acquiring or licensing new products, technologies, or intellectual property rights. This allows them to offer a comprehensive range of veterinary medications, vaccines, diagnostics, nutritional supplements, and other healthcare products. Other than this, key players aim to penetrate new markets and expand their geographic presence to leverage untapped opportunities. This involves establishing partnerships, distribution agreements, or acquiring local companies to gain access to new customer bases and distribution networks. Besides this, key players in the market engage in collaborations and partnerships with veterinary clinics, hospitals, research institutions, and universities. These collaborations aim to drive product development, conduct clinical trials, and expand market reach. Moreover, they invest in marketing and promotional activities to create awareness about their products and services. They employ various channels, including digital marketing, conferences, veterinary events, and educational programs, to reach veterinarians, pet owners, and livestock farmers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Archer-Daniels-Midland Company
  • Boehringer Ingelheim GmbH
  • Cargill Incorporated
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Merck & Co. Inc.
  • Neogen Corporation
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.

Recent Developments:

In April 2022, Elanco Animal Health Incorporated, a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of BiomEdit, a microbiome innovation company that is expected to discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines and microbial monitoring services for animal health..

Ceva Sante Animale, acquired Artemis Technologies Inc., this strategic move allows Ceva Sante Animale to enhance its portfolio of products dedicated to combating rabies in animals.

Archer-Daniels-Midland Company recently acquired a license for Gnubiotics AMOBIOME, a cutting-edge technology for use in pet food and supplement formulas. Gnubiotics AMOBIOME is a unique prebiotic that targets specific beneficial bacteria in the gut microbiome of animals.

Key Questions Answered in This Report

  • 1.What was the size of the global veterinary medicine market in 2024?
  • 2.What is the expected growth rate of the global veterinary medicine market during 2025-2033?
  • 3.What are the key factors driving the global veterinary medicine market?
  • 4.What has been the impact of COVID-19 on the global veterinary medicine market?
  • 5.What is the breakup of the global veterinary medicine market based on the animal type?
  • 6.What is the breakup of the global veterinary medicine market based on the route of administration?
  • 7.What is the breakup of the global veterinary medicine market based on the distribution channel?
  • 8.What are the key regions in the global veterinary medicine market?
  • 9.Who are the key players/companies in the global veterinary medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-infective
      • 6.1.2.2 Anti-inflammatory
      • 6.1.2.3 Parasiticide
    • 6.1.3 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Inactivated Vaccines
      • 6.2.2.2 Attenuated Vaccines
      • 6.2.2.3 Recombinant Vaccines
    • 6.2.3 Market Forecast
  • 6.3 Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Amino Acids
      • 6.3.2.2 Antibiotics
    • 6.3.3 Market Forecast

7 Market Breakup by Animal Type

  • 7.1 Production
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Companion
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Parenteral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Point-of-Care Testing/In-house Testing
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Archer-Daniels-Midland Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Boehringer Ingelheim GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Cargill Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Ceva Sante Animale
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dechra Pharmaceuticals PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Elanco Animal Health Incorporated
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Merck & Co. Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Neogen Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Vetoquinol S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Virbac
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Zoetis Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Veterinary Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Medicine Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Veterinary Medicine Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Veterinary Medicine Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Veterinary Medicine Market: Breakup by Animal Type (in %), 2024
  • Figure 6: Global: Veterinary Medicine Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Veterinary Medicine Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Veterinary Medicine Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Veterinary Medicine (Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Veterinary Medicine (Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Veterinary Medicine (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Veterinary Medicine (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Veterinary Medicine (Medicated Feed Additives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Veterinary Medicine (Medicated Feed Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Veterinary Medicine (Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Veterinary Medicine (Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Veterinary Medicine (Companion) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Veterinary Medicine (Companion) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Veterinary Medicine (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Veterinary Medicine (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Veterinary Medicine (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Veterinary Medicine (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Veterinary Medicine (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Veterinary Medicine (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Veterinary Medicine (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Veterinary Medicine (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Veterinary Medicine (Point-of-Care Testing/In-house Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Veterinary Medicine (Point-of-Care Testing/In-house Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Veterinary Medicine (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Veterinary Medicine (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Veterinary Medicine Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Veterinary Medicine Industry: SWOT Analysis
  • Figure 81: Global: Veterinary Medicine Industry: Value Chain Analysis
  • Figure 82: Global: Veterinary Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Medicine Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Veterinary Medicine Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Veterinary Medicine Market Forecast: Breakup by Animal Type (in Million USD), 2025-2033
  • Table 4: Global: Veterinary Medicine Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Veterinary Medicine Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Veterinary Medicine Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Veterinary Medicine Market: Competitive Structure
  • Table 8: Global: Veterinary Medicine Market: Key Players